<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36188407</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Oculomotor, vestibular, reaction time, and cognitive tests as objective measures of neural deficits in patients post COVID-19 infection.</ArticleTitle><Pagination><StartPage>919596</StartPage><MedlinePgn>919596</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">919596</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2022.919596</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">An alarming proportion (&gt;30%) of patients affected by SARS-CoV-2 (COVID-19) continue to experience neurological symptoms, including headache, dizziness, smell and/or taste abnormalities, and impaired consciousness (brain fog), after recovery from the acute infection. These symptoms are self-reported and vary from patient to patient, making it difficult to accurately diagnose and initiate a proper treatment course. Objective measures to identify and quantify neural deficits underlying the symptom profiles are lacking. This study tested the hypothesis that oculomotor, vestibular, reaction time, and cognitive (OVRT-C) testing using eye-tracking can objectively identify and measure functional neural deficits post COVID-19 infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Subjects diagnosed with COVID-19 (<i>n</i> = 77) were tested post-infection with a battery of 20 OVRT-C tests delivered on a portable eye-tracking device (Neurolign Dx100). Data from 14 tests were compared to previously collected normative data from subjects with similar demographics. Post-COVID subjects were also administered the Neurobehavioral Symptom Inventory (NSI) for symptom evaluation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A significant percentage of post COVID-19 patients (up to 86%) scored outside the norms in 12 out of 14 tests, with smooth pursuit and optokinetic responses being most severely affected. A multivariate model constructed using stepwise logistic regression identified 6 metrics as significant indicators of post-COVID patients. The area under the receiver operating characteristic curve (AUC) was 0.89, the estimated specificity was 98% (with cutoff value of 0.5) and the sensitivity was 88%. There were moderate but significant correlations between NSI domain key variables and OVRT-C tests.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">This study demonstrates the feasibility of OVRT-C testing to provide objective measures of neural deficits in people recovering from COVID-19 infection. Such testing may serve as an efficient tool for identifying hidden neurological deficits post COVID-19, screening patients at risk of developing long COVID, and may help guide rehabilitation and treatment strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Kelly, Anghinah, Kullmann, Ashmore, Synowiec, Gibson, Manfrinati, Ara&#xfa;jo, Spera, Brucki, Tuma, Braverman and Kiderman.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Kevin M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Neurology Department, Allegheny Health Network, Pittsburgh, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anghinah</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neurology Department at Clinical Hospital of Medical School of University of S&#xe1;o Paulo, S&#xe1;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Department of Athletes Union of S&#xe1;o Paulo, S&#xe1;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kullmann</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurolign USA LLC, A Subsidiary of Neurolign Technologies Inc., Pittsburgh, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashmore</LastName><ForeName>R C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Neurolign USA LLC, A Subsidiary of Neurolign Technologies Inc., Pittsburgh, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Synowiec</LastName><ForeName>A S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Neurology Department, Allegheny Health Network, Pittsburgh, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibson</LastName><ForeName>L C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Neurolign USA LLC, A Subsidiary of Neurolign Technologies Inc., Pittsburgh, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manfrinati</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurology Department at Clinical Hospital of Medical School of University of S&#xe1;o Paulo, S&#xe1;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Department of Athletes Union of S&#xe1;o Paulo, S&#xe1;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Ara&#xfa;jo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Department at Clinical Hospital of Medical School of University of S&#xe1;o Paulo, S&#xe1;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spera</LastName><ForeName>R R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Neurology Department at Clinical Hospital of Medical School of University of S&#xe1;o Paulo, S&#xe1;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brucki</LastName><ForeName>S M D</ForeName><Initials>SMD</Initials><AffiliationInfo><Affiliation>Neurology Department at Clinical Hospital of Medical School of University of S&#xe1;o Paulo, S&#xe1;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuma</LastName><ForeName>R L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Neurology Department at Clinical Hospital of Medical School of University of S&#xe1;o Paulo, S&#xe1;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braverman</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurolign USA LLC, A Subsidiary of Neurolign Technologies Inc., Pittsburgh, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiderman</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurolign USA LLC, A Subsidiary of Neurolign Technologies Inc., Pittsburgh, PA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Neurobehavioral Symptom Inventory (NSI)</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">eye-tracking</Keyword><Keyword MajorTopicYN="N">oculomotor</Keyword></KeywordList><CoiStatement>Author AKi is the VP Technology Development, employee of, and shareholder of Neurolign USA LLC. Author RAs is an employee of and shareholder of Neurolign USA LLC. Author LG is an employee of Neurolign USA LLC. Author RAn received funding support from Neurolign USA LLC. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36188407</ArticleId><ArticleId IdType="pmc">PMC9516636</ArticleId><ArticleId IdType="doi">10.3389/fneur.2022.919596</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. . Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. (2020) 7:611&#x2013;27. 10.1016/S2215-0366(20)30203-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Rom&#xe1;n GC, Spencer PS, Reis J, Buguet A, Faris MEA, L&#xe1;inez M, et al. . The neurology of COVID-19 revisited: a proposal from the environmental neurology specialty group of the world federation of neurology to implement internation neurological registries. J Neurol Sci. (2020) 414:1&#x2013;12. 10.1016/j.jns.2020.116884</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116884</ArticleId><ArticleId IdType="pmc">PMC7204734</ArticleId><ArticleId IdType="pubmed">32464367</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ramadan A. Rabab'h O, Shah J, Gharaibeh A. Acute and post-acute neurological complications of COVID-19. Neurol Int. (2021) 13:102&#x2013;19. 10.3390/neurolint13010010</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint13010010</ArticleId><ArticleId IdType="pmc">PMC8006051</ArticleId><ArticleId IdType="pubmed">33803475</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson CJ, Sarangi A, Bangash F. Neurological sequelae of COVID-19: a review. Egypt J Neurol Psychiatr Neurosurg. (2021) 57:122. 10.1186/s41983-021-00379-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41983-021-00379-0</ArticleId><ArticleId IdType="pmc">PMC8424148</ArticleId><ArticleId IdType="pubmed">34511868</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, et al. . Frequent neurologic manifestations and encephalopathy-associated morbidity in COVID-19 patients. Ann Clin Transl Neurol. (2020) 7:2221&#x2013;30. 10.1002/acn3.51210</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51210</ArticleId><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SH-Y, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V, et al. . Global incidence of neurological manifestations among patients hospitalized with COVID-19 &#x2013; a report for the GCS-NeuroCOVID Consortium and the ENERGY Constortium. JAMA Network Open. (2021) 4:e2112131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114143</ArticleId><ArticleId IdType="pubmed">33974053</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Laurent S, Onure OA, Kleineberg NN, Fink GR, Schweitzer F, et al. . A systematic review of neurological symptoms and complications of COVID-19. J Neurol. (2021) 268:392&#x2013;402. 10.1007/s00415-020-10067-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10067-3</ArticleId><ArticleId IdType="pmc">PMC7370630</ArticleId><ArticleId IdType="pubmed">32691236</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Khaleeq A, Ali U. Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. (2020) 11:995&#x2013;8. 10.1021/acschemneuro.0c00122</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Samavati L, Uhal BD. ACE2, much more than just a receptor for SARS-CoV-2. Front Cell Infect Microbiol. (2020) 10:1&#x2013;9. 10.3389/fcimb.2020.00317</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00317</ArticleId><ArticleId IdType="pmc">PMC7294848</ArticleId><ArticleId IdType="pubmed">32582574</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, et al. . Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. (2020) 19:919&#x2013;29. 10.1016/S1474-4422(20)30308-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulfamante G, Bocci T, Falleni M, Campiglio L, Coppola S, Tosi D, et al. . Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung. J. Neurol. (2021) 268:4486&#x2013;91. 10.1007/s00415-021-10604-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10604-8</ArticleId><ArticleId IdType="pmc">PMC8129960</ArticleId><ArticleId IdType="pubmed">34003372</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen MP, Le Quesne J, Officer-Jonest L, Teod&#xf2;sio A, Thaventhiran J, Ficken C, et al. . Neuropathological findings in two patients with fatal COVID-19. Neuropathol Appl Neurobiol. (2020) 47:17&#x2013;25. 10.1111/nan.12662</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12662</ArticleId><ArticleId IdType="pubmed">32895961</ArticleId></ArticleIdList></Reference><Reference><Citation>Siow I, Lee KS, Zhang JJY, Saffari SE, Ng A. Stroke as a neurological complication of COVID-19: a systematic review and meta-analysis of incidence, outcomes and predictors. J Stroke Cerebrovasc Dis. (2021) 30:105549. 10.1016/j.jstrokecerebrovasdis.2020.105549</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105549</ArticleId><ArticleId IdType="pmc">PMC7834121</ArticleId><ArticleId IdType="pubmed">33341565</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol. (2020) 95:1578&#x2013;89. 10.1002/ajh.25982</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25982</ArticleId><ArticleId IdType="pmc">PMC7674272</ArticleId><ArticleId IdType="pubmed">32857878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract. (2020) 10:1271. 10.4081/cp.2020.1271</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/cp.2020.1271</ArticleId><ArticleId IdType="pmc">PMC7267810</ArticleId><ArticleId IdType="pubmed">32509258</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade BS, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, dos Santos Freitas A, et al. . Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. (2021) 13:700. 10.3390/v13040700</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. (2021) 8:416&#x2013;27. 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al. . Sequelae in adults at 6 months after COVID-19 infection. JAMA Network Open. (2021) 4:e210830. 10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Teneforde MW, Billig Rose E, Lindsell CJ, Shapiro NI, Files DC, Gibbs KW, et al. . Characteristics of adult outpatients and inpatients with COVID-19. MMWR. (2020) 69:841&#x2013;6. 10.15585/mmwr.mm6926e3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6926e3</ArticleId><ArticleId IdType="pmc">PMC7332092</ArticleId><ArticleId IdType="pubmed">32614810</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professions. Arch Med Res. (2021) 52:575&#x2013;81. 10.1016/j.arcmed.2021.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EclinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. . Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. (2021) 39:101044. 10.1016/j.eclinm.2021.101044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly KM, Kiderman A, Akhavan S, Quigley MR, Snell ED, Happ E, et al. . Oculomotor, vestibular, and reaction time effects of sports-related concussion: video-oculography in assessing sports-related concussion. J Head Trauma Rehabil. (2018) 34:176&#x2013;88. 10.1097/HTR.0000000000000437</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HTR.0000000000000437</ArticleId><ArticleId IdType="pmc">PMC6553977</ArticleId><ArticleId IdType="pubmed">30234848</ArticleId></ArticleIdList></Reference><Reference><Citation>Balaban C, Hoffer ME, Szczupak M, Snapp H, Crawford J, Murphy S, et al. . Oculomotor, vestibular, and reaction time tests in mild traumatic brain injury. PLoS ONE. (2016) 11:e0162168. 10.1371/journal.pone.0162168</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0162168</ArticleId><ArticleId IdType="pmc">PMC5031310</ArticleId><ArticleId IdType="pubmed">27654131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SL, Shaikh AG, Ghasia FF. Vergence and strabismus in neurodegenerative disorders. Front Neurol. (2018) 9:1&#x2013;10. 10.3389/fneur.2018.00299</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00299</ArticleId><ArticleId IdType="pmc">PMC5964131</ArticleId><ArticleId IdType="pubmed">29867716</ArticleId></ArticleIdList></Reference><Reference><Citation>Crutcher MD, Calhoun-Haney R, Manzanares LJJ, Levey AI, Zola SM. Eye tracking during a visual paired comparison task as a predictor of early dementia. Am J Alzheimers Dis Other Demen. (2009) 24:258&#x2013;66. 10.1177/1533317509332093</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317509332093</ArticleId><ArticleId IdType="pmc">PMC2701976</ArticleId><ArticleId IdType="pubmed">19246573</ArticleId></ArticleIdList></Reference><Reference><Citation>Golding CVP, Danchaivijitr TL, Hodgson SJ, Kennard TC. Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology. (2006) 67:485&#x2013;7. 10.1212/01.wnl.0000218215.43328.88</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000218215.43328.88</ArticleId><ArticleId IdType="pubmed">16625001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks SL, Robert MPA, Golding CVP, Tabrizi SJ, Kennard C. Oculomotor deficits indicate progression of Huntington's disease. Prog Brain Res. (2008) 171:555&#x2013;8. 10.1016/S0079-6123(08)00678-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0079-6123(08)00678-X</ArticleId><ArticleId IdType="pubmed">18718352</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra A, Chisari CG, Matta M. Eye movement abnormalities in multiple sclerosis: pathogenesis, modeling, and treatment. Front Neurol. (2018) 9:31. 10.3389/fneur.2018.00031</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00031</ArticleId><ArticleId IdType="pmc">PMC5807658</ArticleId><ArticleId IdType="pubmed">29467711</ArticleId></ArticleIdList></Reference><Reference><Citation>Cena CG, Costa MC, Saltar&#xe9;n Pazmi&#xf1;o R, Santos CP, G&#xf3;mez-Andr&#xe9;s D, Benito-Le&#xf3;n J, et al. . Eye movement alterations in post-COVID-19 condition: a proof-of-concept study. Sensors. (2022) 22:1481. 10.3390/s22041481</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s22041481</ArticleId><ArticleId IdType="pmc">PMC8875414</ArticleId><ArticleId IdType="pubmed">35214383</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan M, Cengiz DU, Demir I, Demirel S, &#xc7;olak SC, Karakas O, et al. . Effects of COVID-19 on the audio-vestibular system. Med Surg. (2022) 43:103173. 10.1016/j.amjoto.2021.103173</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.103173</ArticleId><ArticleId IdType="pmc">PMC8352672</ArticleId><ArticleId IdType="pubmed">34392022</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfar-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. (2022) 604:697&#x2013;707. 10.1101/2021.06.11.21258690</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.11.21258690</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullman A, Ashmore RC, Braverman A, Mazur C, Snapp H, Williams E, et al. . Portable eye-tracking as a reliable assessment of oculomotor, cognitive and reaction time function: normative data for 18-45 year old. PLoS ONE. (2021) 16:e0260351. 10.1371/journal.pone.0260351</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260351</ArticleId><ArticleId IdType="pmc">PMC8608311</ArticleId><ArticleId IdType="pubmed">34807938</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullman A, Ashmore RC, Braverman A, Mazur C, Snapp H, Willians BS, et al. . Normative data for ages 18-45 for ocular and vestibular testing using eye tracking. Laryngoscope Investig Otolaryngol. (2021) 6:1116&#x2013;27. 10.1002/lio2.632</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lio2.632</ArticleId><ArticleId IdType="pmc">PMC8513422</ArticleId><ArticleId IdType="pubmed">34667856</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderploeg RD, Silva MA, Soble JR, Curtiss G, Belanger HG, Donnell AJ, et al. . The structure of postconcussion symptoms on the neurobehavioral symptom inventory: a comparison of alternative models. J Head Trauma Rehabil. (2015) 30:1&#x2013;11. 10.1097/HTR.0000000000000009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HTR.0000000000000009</ArticleId><ArticleId IdType="pubmed">24263177</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, Wing YK Yu MW, Leung C, Ma RCW, Kong APS, et al. . Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. (2009) 169:2142&#x2013;7. 10.1001/archinternmed.2009.384</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen NW, Stiles LE, Miglis MG. Preparing for the long-haul: autonomic complications of COVID-19. Auton Neurosci. (2021) 235:102841. 10.1016/j.autneu.2021.102841</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102841</ArticleId><ArticleId IdType="pmc">PMC8254396</ArticleId><ArticleId IdType="pubmed">34265539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Medicina. (2021) 57:418. 10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. (2019) 7:12. 10.3389/fped.2019.00012</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00012</ArticleId><ArticleId IdType="pmc">PMC6370741</ArticleId><ArticleId IdType="pubmed">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. (2006) 333:575. 10.1136/bmj.38933.585764.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. (2021) 53:737&#x2013;54. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, et al. . Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci USA. (2017) 114:E7150&#x2013;8. 10.1073/pnas.1710519114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710519114</ArticleId><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med. (2021) 7:606824. 10.3389/fmed.2020.606824</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirfazeli FS, Sarabi-Jamab A, Pereira-Sanchez V, Kordi A, Shariati B, Shariat SV, et al. . Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: a 9-month follow-up study. Neurol Sci. (2022) 43:2231&#x2013;9. 10.1007/s10072-021-05786-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05786-y</ArticleId><ArticleId IdType="pmc">PMC8776380</ArticleId><ArticleId IdType="pubmed">35059902</ArticleId></ArticleIdList></Reference><Reference><Citation>Badham SP, Hutchinson CV. Characterising eye movement dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. Graefes Arch Clin Exp Ophthalmol. (2013) 251:2769&#x2013;76. 10.1007/s00417-013-2431-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-013-2431-3</ArticleId><ArticleId IdType="pubmed">23918092</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth PH, Gadebusch-Bondio M. The contested meaning of &#x201c;long COVID&#x201d; - Patients, doctors, and the politics of subjective evidence. Soc Sci Med. (2022) 292:114619. 10.1016/j.socscimed.2021.114619</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2021.114619</ArticleId><ArticleId IdType="pmc">PMC8629766</ArticleId><ArticleId IdType="pubmed">34906823</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>